| 1 | GPRE | GREEN PLAINS INC. TTM · 2026-06-30 | Chemicals | $1.0B | 167.1% |
| 2 | NKTR | Nektar Therapeutics FY · 2025-12-31 | Other | $1.4B | 100.0% |
| 3 | MGNX | MACROGENICS, INC. FY · 2025-12-31 | Other | $238M | 100.0% |
| 4 | ABVC | ABVC BioPharma, Inc. FY · 2024-12-31 | Other | $27M | 99.9% |
| 5 | LXRX | LEXICON PHARMACEUTICALS, INC. FY · 2025-12-31 | Other | $748M | 99.4% |
| 6 | AGEN | AGENUS INC FY · 2025-12-31 | Other | $346M | 99.1% |
| 7 | CORT | CORCEPT THERAPEUTICS INC TTM · 2026-06-30 | Other | $13.1B | 98.3% |
| 8 | IONS | IONIS PHARMACEUTICALS, INC. TTM · 2026-06-30 | Other | $7.5B | 98.2% |
| 9 | NBIX | NEUROCRINE BIOSCIENCES, INC. TTM · 2026-06-30 | Other | $14.5B | 98.0% |
| 10 | BCRX | BIOCRYST PHARMACEUTICALS, INC. TTM · 2026-06-30 | Other | $2.2B | 97.8% |
| 11 | EXEL | Exelixis Inc TTM · 2026-07-03 | Other | $14.8B | 96.5% |
| 12 | GYRE | Gyre Therapeutics, Inc. FY · 2025-12-31 | Other | $746M | 95.4% |
| 13 | RIGL | RIGEL PHARMACEUTICALS, INC. TTM · 2026-06-30 | Other | $917M | 91.4% |
| 14 | ACAD | ACADIA PHARMACEUTICALS INC. TTM · 2026-06-30 | Other | $3.4B | 91.1% |
| 15 | MNKD | MannKind Corporation TTM · 2026-06-30 | Other | $1.1B | 89.8% |
| 16 | CLDX | Celldex Therapeutics, Inc. FY · 2025-12-31 | Other | $2.3B | 87.1% |
| 17 | CDXS | Codexis, Inc. TTM · 2026-06-30 | Chemicals | $154M | 87.0% |
| 18 | VRTX | VERTEX PHARMACEUTICALS INC / MA FY · 2025-12-31 | Other | $129.3B | 86.2% |
| 19 | UTHR | United Therapeutics Corporation TTM · 2026-06-30 | Other | $23.6B | 86.1% |
| 20 | CPIX | Cumberland Pharmaceuticals Inc. FY · 2025-12-31 | Other | $105M | 85.0% |
| 21 | ERNA | Ernexa Therapeutics Inc. FY · 2024-12-31 | Other | $3M | 83.5% |
| 22 | INSM | INSMED INC TTM · 2026-06-30 | Other | $22.0B | 83.5% |
| 23 | LLY | ELI LILLY AND COMPANY FY · 2025-12-31 | Other | $1.1T | 83.0% |
| 24 | HALO | HALOZYME THERAPEUTICS, INC. TTM · 2026-06-30 | Other | $12.5B | 82.4% |
| 25 | TGTX | TG THERAPEUTICS, INC. TTM · 2026-06-30 | Other | $8.5B | 82.4% |
| 26 | ALNY | ALNYLAM PHARMACEUTICALS, INC. TTM · 2026-06-30 | Other | $31.1B | 79.8% |
| 27 | GILD | GILEAD SCIENCES, INC. TTM · 2026-06-30 | Other | $187.4B | 79.6% |
| 28 | NVAX | NOVAVAX, INC. TTM · 2026-06-30 | Other | $2.1B | 78.6% |
| 29 | LFVN | LIFEVANTAGE CORP FY · 2026-06-30 | Other | $76M | 77.6% |
| 30 | USNA | USANA HEALTH SCIENCES, INC. TTM · 2026-07-04 | Other | $271M | 77.4% |
| 31 | BMRN | BIOMARIN PHARMACEUTICAL INC TTM · 2026-06-30 | Other | $10.6B | 76.1% |
| 32 | EL | Estee Lauder Companies Inc FY · 2026-06-30 | Other | $35.5B | 75.5% |
| 33 | BIIB | BIOGEN INC. TTM · 2026-03-31 | Other | $33.3B | 75.5% |
| 34 | MTEX | MANNATECH INC FY · 2025-12-31 | Other | $15M | 74.9% |
| 35 | INVA | INNOVIVA, INC. FY · 2025-12-31 | Other | $1.5B | 74.8% |
| 36 | VCEL | VERICEL CORPORATION FY · 2025-12-31 | Other | $2.1B | 74.4% |
| 37 | ABEO | ABEONA THERAPEUTICS INC. FY · 2025-12-31 | Other | $282M | 73.7% |
| 38 | HRTX | HERON THERAPEUTICS, INC. /DE/ FY · 2025-12-31 | Other | $77M | 73.3% |
| 39 | PFE | PFIZER INC TTM · 2026-06-28 | Other | $161.2B | 73.2% |
| 40 | NATR | NATURE’S SUNSHINE PRODUCTS, INC. TTM · 2026-06-30 | Other | $222M | 73.2% |
| 41 | MRK | Merck & Co., Inc. TTM · 2026-06-30 | Other | $359.2B | 73.0% |
| 42 | ZTS | Zoetis Inc. TTM · 2026-06-30 | Other | $30.9B | 71.5% |
| 43 | BMY | BRISTOL-MYERS SQUIBB COMPANY TTM · 2026-06-30 | Other | $120.8B | 70.2% |
| 44 | AMGN | Amgen Inc. TTM · 2026-06-30 | Other | $224.3B | 69.5% |
| 45 | PLX | PROTALIX BIOTHERAPEUTICS, INC. TTM · 2026-06-30 | Other | $224M | 69.2% |
| 46 | MYGN | MYRIAD GENETICS, INC. TTM · 2026-06-30 | Other | $412M | 68.8% |
| 47 | JNJ | Johnson & Johnson FY · 2025-12-28 | Other | $630.0B | 67.9% |
| 48 | CELZ | Creative Medical Technology Holdings, Inc. TTM · 2026-06-30 | Other | $6M | 66.9% |
| 49 | TECH | BIO-TECHNE Corp FY · 2026-06-30 | Other | $11.4B | 65.8% |
| 50 | IPAR | INTERPARFUMS, INC. TTM · 2026-06-30 | Other | $3.6B | 63.8% |
| 51 | COTY | | Other | $2.5B | 62.9% |
| 52 | IDXX | IDEXX LABORATORIES INC /DE TTM · 2026-06-30 | Other | $40.8B | 62.4% |
| 53 | CL | COLGATE-PALMOLIVE COMPANY TTM · 2026-06-30 | Other | $70.4B | 60.4% |
| 54 | ANIP | ANI PHARMACEUTICALS, INC TTM · 2026-06-30 | Other | $1.7B | 60.4% |
| 55 | KVUE | Kenvue Inc. TTM · 2026-06-28 | Other | $34.0B | 58.2% |
| 56 | AMRN | AMARIN CORP PLC\UK FY · 2025-12-31 | Other | $254M | 56.6% |
| 57 | ABT | ABBOTT LABORATORIES TTM · 2026-03-31 | Other | $172.3B | 56.3% |
| 58 | WDFC | WD-40 COMPANY TTM · 2026-05-31 | Chemicals | $2.7B | 55.8% |
| 59 | PRM | PERIMETER SOLUTIONS, INC. TTM · 2026-06-30 | Chemicals | $4.5B | 54.7% |
| 60 | SIGA | Siga Technologies INC TTM · 2026-06-30 | Other | $236M | 54.4% |
| 61 | RGEN | REPLIGEN CORP TTM · 2026-06-30 | Other | $11.0B | 53.8% |
| 62 | TOMZ | TOMI ENVIRONMENTAL SOLUTIONS, INC. TTM · 2026-06-30 | Chemicals | $13M | 52.9% |
| 63 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED FY · 2025-12-31 | Other | $47.9B | 51.8% |
| 64 | GEVO | GEVO, INC. TTM · 2026-06-30 | Chemicals | $326M | 51.2% |
| 65 | PG | PROCTER & GAMBLE CO FY · 2026-06-30 | Other | $351.3B | 50.2% |
| 66 | LAB | Standard BioTools Inc. FY · 2025-12-31 | Other | $271M | 49.9% |
| 67 | CSBR | CHAMPIONS ONCOLOGY, INC. TTM · 2026-07-31 | Other | $67M | 49.8% |
| 68 | LIN | Linde plc TTM · 2026-06-30 | Chemicals | $223.0B | 48.3% |
| 69 | CYRX | CRYOPORT, INC. TTM · 2026-06-30 | Other | $879M | 47.1% |
| 70 | NEOG | Neogen Corporation FY · 2026-05-31 | Other | $2.6B | 46.9% |
| 71 | UG | UNITED-GUARDIAN, INC. TTM · 2026-06-30 | Other | $32M | 46.9% |
| 72 | CHD | CHURCH & DWIGHT CO., INC. FY · 2025-12-31 | Other | $23.3B | 44.7% |
| 73 | PLUR | PLURI INC. FY · 2026-06-30 | Other | $12M | 44.6% |
| 74 | ECL | ECOLAB INC. TTM · 2026-06-30 | Other | $79.0B | 44.1% |
| 75 | CLX | CLOROX CO /DE/ TTM · 2026-03-31 | Other | $10.1B | 43.8% |
| 76 | CF | CF INDUSTRIES HOLDINGS, INC. TTM · 2026-06-30 | Chemicals | $16.9B | 42.5% |
| 77 | ICCC | ImmuCell Corporation FY · 2025-12-31 | Other | $89M | 41.4% |
| 78 | PPG | PPG INDUSTRIES INC TTM · 2026-03-31 | Chemicals | $23.1B | 41.4% |
| 79 | RPM | RPM International Inc. TTM · 2026-08-31 | Chemicals | $12.5B | 41.1% |
| 80 | OPK | OPKO Health, Inc. TTM · 2026-06-30 | Other | $1.0B | 40.8% |
| 81 | PACK | RANPAK HOLDINGS CORP. TTM · 2026-06-30 | Paper Products | $318M | 40.6% |
| 82 | EPC | EDGEWELL PERSONAL CARE COMPANY TTM · 2026-06-30 | Other | $1.3B | 40.4% |
| 83 | NGVT | INGEVITY CORPORATION FY · 2025-12-31 | Chemicals | $2.4B | 39.5% |
| 84 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC TTM · 2026-06-30 | Chemicals | $21.6B | 38.9% |
| 85 | KMB | KIMBERLY-CLARK CORPORATION TTM · 2026-06-30 | Paper Products | $32.5B | 36.8% |
| 86 | BCPC | Balchem Corporation TTM · 2026-06-30 | Chemicals | $5.4B | 36.3% |
| 87 | FMC | FMC CORPORATION TTM · 2026-06-30 | Chemicals | $1.3B | 35.3% |
| 88 | VTRS | VIATRIS INC. TTM · 2026-06-30 | Other | $20.3B | 34.9% |
| 89 | SXT | Sensient Technologies Corp TTM · 2026-06-30 | Chemicals | $5.5B | 34.6% |
| 90 | AXTA | AXALTA COATING SYSTEMS LTD. TTM · 2026-03-31 | Chemicals | $7.0B | 34.2% |
| 91 | PAHC | Phibro Animal Health Corporation FY · 2026-06-30 | Other | $1.6B | 33.8% |
| 92 | FUL | FULLER H B CO TTM · 2026-08-29 | Chemicals | $2.7B | 32.3% |
| 93 | SMG | Scotts Miracle-Gro Co TTM · 2026-06-27 | Chemicals | $2.9B | 32.3% |
| 94 | DSY | BIG TREE CLOUD HOLDINGS LIMITED FY · 2025-06-30 | Paper Products | $17M | 32.2% |
| 95 | ROG | ROGERS CORP TTM · 2026-03-31 | Chemicals | $2.6B | 32.2% |
| 96 | SOLS | Solstice Advanced Materials Inc. FY · 2025-12-31 | Chemicals | $9.7B | 32.2% |
| 97 | NL | NLI HOLDINGS, INC. TTM · 2026-06-30 | Chemicals | $339M | 32.1% |
| 98 | APD | AIR PRODUCTS AND CHEMICALS, INC. TTM · 2026-06-30 | Chemicals | $62.6B | 32.1% |
| 99 | NEU | NEWMARKET CORPORATION TTM · 2026-06-30 | Chemicals | $8.2B | 31.5% |
| 100 | LFCR | LIFECORE BIOMEDICAL, INC. FY · 2025-05-25 | Other | $244M | 31.3% |